Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$280K Buy
17,330
+3,840
+28% +$45.4K ﹤0.01% 1304
2025
Q4
$50.2K Hold
13,490
﹤0.01% 1523
2025
Q3
$29.4K Hold
13,490
﹤0.01% 1513
2025
Q2
$17.1K Buy
13,490
+374
+3% +$501 ﹤0.01% 1501
2025
Q1
$18K Buy
13,116
+723
+6% +$1.24K ﹤0.01% 1429
2024
Q4
$31.1K Buy
12,393
+1,103
+10% +$3.02K ﹤0.01% 1419
2024
Q3
$30.8K Buy
+11,290
New +$31.8K ﹤0.01% 1367

Other funds holding ERAS

Xponance's ERAS Position: Q1 2026 in Review

Xponance increased its Erasca (ERAS) stake by 28% in Q1 2026, buying an estimated $45.4K and bringing the position to 17,330 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Xponance first reported a position in ERAS in Q3 2024 and has held it in 7 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Xponance held 17,330 shares of Erasca worth $280K as of Q1 2026.
  • Xponance bought 3,840 Erasca shares in Q1 2026, an estimated $45.4K.
  • Erasca made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1304 holding.
  • Xponance first reported a position in Erasca in Q3 2024 and has held it in 7 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.